Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs Sufentanil PCA for Postoperative Pain in AICU After Abdominal Surgery
ChiCTR2600116254Phase 4Not yet recruiting
- Sponsor
- Union Hospital of Huazhong University of Science and Technology
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in acute postoperative pain (2 arms), sponsored by Union Hospital of Huazhong University of Science and Technology. Primary endpoint: NRS score at 24 hours. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2600116254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116254.